Jennifer Kamocsay
General Counsel at AKOYA BIOSCIENCES, INC.
Net worth: 379 009 $ as of 29/04/2024
Profile
Jennifer Kamocsay is currently the General Counsel at Akoya Biosciences, Inc. She previously worked as the Associate General Counsel at Progress Software Corp.
and as the General Counsel at Rubius Therapeutics, Inc. Ms. Kamocsay received an undergraduate degree from the University of California and a graduate degree from Northeastern University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AKOYA BIOSCIENCES INC
0.20% | 29/02/2024 | 99,217 ( 0.20% ) | 379 009 $ | 29/04/2024 |
Jennifer Kamocsay active positions
| Companies | Position | Start |
|---|---|---|
| AKOYA BIOSCIENCES, INC. | General Counsel | 27/02/2023 |
Former positions of Jennifer Kamocsay
| Companies | Position | End |
|---|---|---|
| PROGRESS SOFTWARE CORPORATION | Corporate Officer/Principal | - |
| RUBIUS THERAPEUTICS | General Counsel | - |
Training of Jennifer Kamocsay
| University of California | Undergraduate Degree |
| Northeastern University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AKOYA BIOSCIENCES, INC. | Health Technology |
| PROGRESS SOFTWARE CORPORATION | Technology Services |
| Private companies | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Kamocsay
